A NERA Briefing: Expert Workshop on HTA

Thu Dec 13 15:24:38 EST 2007

This briefing note summarizes key points arising from an expert workshop on Health Technology Assessment (HTA). The workshop was attended by UK-based experts across a range of fields including economics, epidemiology, evidence-based medicine, and policy, as well as by Pfizer, which represented the research-based pharmaceutical industry. The aim of the workshop was to "develop a shared view of how HTA can inform decision-making in the future, based on what stakeholders know about current developments in HTA and the needs of policymakers to have information earlier to make better-evidenced decisions." NERA's brief describes HTA in the English and Welsh context, challenges faced when conducting HTA and implementing HTA findings, and areas that would benefit from future research.